Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
11.46
+0.29 (2.63%)
Feb 17, 2026, 2:49 PM EST - Market open
Korro Bio Market Cap
Korro Bio has a market cap or net worth of $107.96 million as of February 17, 2026. Its market cap has decreased by -66.28% in one year.
Market Cap
107.96M
Enterprise Value
49.34M
1-Year Change
-66.28%
Ranking
Category
Stock Price
$11.46
Market Cap Chart
Since November 6, 2023, Korro Bio's market cap has decreased from $123.80M to $107.96M, a decrease of -12.79%. That is a compound annual growth rate of -5.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 105.19M | 39.45% |
| Dec 31, 2025 | 75.43M | -78.85% |
| Dec 31, 2024 | 356.65M | -6.96% |
| Dec 29, 2023 | 383.31M | 209.63% |
| Nov 6, 2023 | 123.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inovio Pharmaceuticals | 110.61M |
| Fortress Biotech | 108.94M |
| Coya Therapeutics | 107.62M |
| MacroGenics | 107.22M |
| Alpha Cognition | 106.75M |
| Codexis | 106.13M |
| Immunic | 105.67M |
| Cardiff Oncology | 105.08M |